Gilead shares rise after US top court ruling on preventive coverage ...

Gilead shares rise after US top court ruling on preventive coverage ...

Gilead Shares Surge Following Supreme Court Decision on Preventive Care ...

Gilead shares rise after United States approves remdesivir as COVID-19 ...

Gilead Shares Slip on Reports of Planned Dismissal of Preventive Health ...

Gilead’s Yeztugo HIV Shot Poised For Wider Reach After SCOTUS Ruling On ...

Supreme Court to hear case challenging Obamacare’s preventive coverage ...

Appeals Court Pauses Ruling That Threatened Free Preventive Health Care ...

Trump asks Supreme Court for urgent ruling on tariff powers and more ...

Immunomedics shares double after Gilead agrees to buy the cancer ...

Gilead shares tumble after data leak on coronavirus drug trials

Coronavirus: Gilead shares tumble after report that Chinese remdesivir ...

Gilead Shares Rise On Early Peek At Positive Covid-19 Vaccine Data

US judge recuses herself from black-market drug case over Gilead stock ...

Gilead withdraws bladder cancer drug in US after failed trial | Reuters

Trump administration asks Supreme Court to block ruling reinstating ...

Bessent warns Supreme Court ruling against tariffs would be 'gigantic ...

Judges v Trump: Early wave of court injunctions blocks top White House ...

US tariff revenues soar under Trump ahead of looming Supreme Court ...

Hospital sues data analytics company MultiPlan in US court antitrust ...

Gilead Stock Dives After Bread-And-Butter Drug Misses Sales Forecasts ...

Gilead scores major victory in controversial $1 billion dispute with US ...

Gilead quarterly profit falls on COVID sales drop, legal settlement ...

Gilead Scis., Inc. v. United States: United States Court of Federal ...

GOP plans major crackdown on 'nameless, faceless bureaucrats' after ...

Gilead shares jump on drug report - Fort Worth Business Press

Coronavirus: Gilead Sciences’ upbeat treatment report leads big day on ...

Gilead sets US price for Covid-19 drug remdesivir at $3,120 for typical ...

LISTEN: Supreme Court appears likely to uphold ACA's preventive care ...

Gilead Withdraws ADC Trodelvy in Bladder Cancer After Trial Failure ...

Dow jumps 400 points after Gilead coronavirus drug remdesivir showed ...

Gilead stock tumbles after report that Chinese remdesivir trial ...

Gilead Just Made a Big Bet on Immunomedics’ Cancer Treatment. Was the ...

Gilead Sciences, US government settle patent case over HIV prevention ...

Gilead Beats Earnings Expectations After Rocky Quarter - WSJ

Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug ...

Gilead's new HIV prevention shot added to CVS's drug coverage lists ...

Stocks rise, then stall after promising Gilead Covid-19 drug trial

Supreme Court rules Mexico cannot blame U.S. gunmakers for cartel ...

Gilead CEO insists government patent for HIV prevention pill is invalid ...

Trump calls tariff case 'most important' Supreme Court decision ever ...

Tariff case will be a 'close call' when it goes to the Supreme Court ...

Supreme Court upholds federal health task force that sets no-cost ...

Federal Judge Strikes Down Obamacare Requirement for Free Preventive ...

Supreme Court declines case on student's 'only two genders' T-shirt

US to phase out many synthetic food dyes, Kennedy and FDA head say ...

Gilead stock falls on report of HIV prevention cuts

Gilead Sciences Seen Rising 13% on Better Outlook

Leaked Study Data Finds No Benefits Of Remdesivir On Coronavirus ...

Gilead Stock Surges on Strong Results in HIV Drug Study

Gilead buys cancer drug developer Forty Seven for $4.9-billion - The ...

Gilead Asks FDA To Rescind 'Rare Disease' Status For Coronavirus Drug ...

Elevance says healthcare demand tracks expectations after UnitedHealth ...

Gilead Stock Plunges More Than 10% After Failed Lung Cancer Treatment Trial

Covid-19: Gilead withdraws orphan drug designation from potential ...

FDA rejects Gilead hepatitis delta virus drug bulevirtide - San ...

Gilead Profit Tops Expectations Despite Lower COVID Drug Sales, Outlook ...

US Government Files Appeal in High-Stakes HIV PrEP Patent Battle ...

Gilead Sciences Earnings Were Solid. How the S&P 500’s No. 1 Health ...

Here's Why the Best Is Yet to Come for Gilead Sciences, Inc. | The ...

Gilead Stock Prices Tumbles on Report Coronavirus Drug Not Effective

Gilead More than Doubles Original Courses Expectation for Remdesivir to ...

Gilead Sciences Inc CFO Andrew Dickinson Sells 5,000 Shares

Supreme Court wraps up term with key rulings | In The News Now ...

Federal court rejects drugmaker's efforts to end lawsuit claiming they ...

Gilead stock soars on profits from HIV and cancer drugs

Gilead Sciences Inc CFO Andrew Dickinson Sells 5,000 Shares

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed | KPBS ...

Is Gilead Sciences a Buy After Its Most Recent Roadblock? | The Motley Fool

U.S. government contributed research to a Gilead remdesivir patent ...

Gilead Is Buying Immunomedic. What the Bond Market Has to Say About the ...

US government appeals Gilead's trial win in Truvada, Descovy patent ...

Gilead kicks off clinical trial of inhaled remdesivir for less-severe ...

Gilead Chooses Middle Ground in Pricing of Its Coronavirus Drug ...

Trump administration accuses Gilead of infringing government patents ...

Trump Administration Sues Gilead, Maker of H.I.V.-Prevention Drugs ...

Gilead’s Revenue Declines on Waning Sales of Covid-19 Drug - WSJ

Trump bid to expand power goes to Supreme Court

Biotech Shares Slide As Pols Take Aim At Gilead's Pricing - WSJ

Kennedy's firing of independent CDC advisers undermines vaccine ...

Gilead Gets U.S. Approval to Sell New Hepatitis C Drug - WSJ

Will the Supreme Court view Trump's tariffs like Biden's policies?

Gilead’s Covid-19 Drug Is Mediocre. It Will Be a Blockbuster Anyway ...

U.S. Supreme Court to issue several major rulings | CNN

Gilead’s HIV-prevention drug cut infections by 96%, boosting stock ...

Bet Big on Treatments for Coronavirus - WSJ

Gilead Sciences Stock at Cusp of New Uptrend

Southern District of New York | U.S. Attorney Announces $202 Million ...

Incyte expects minimal tariff hit, lifts blood cancer drug's 2025 ...

FDA Puts Gilead’s HIV Combo Trials on Hold

Coronavirus: WHO tells doctors don't use Gilead's remdesivir, splitting ...

Blockbuster PrEP Lawsuit: Gilead Wins Over U.S. Government

Gilead Resolves Patent Litigations for HIV Treatment Biktarvy

Gilead Sciences beats earnings, revenues expectations

Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed ...

Gilead Stock Is Worth Owning With or Without a Coronavirus Cure

Gilead and the billion-dollar odyssey

Gilead may charge $4,500 for coronavirus treatment drug, report reveals

PrEP4All Claims Gilead Held Back Safer HIV Drug

Gilead's New Anti-Obesity Drug: Real Reason Behind 25% Stock Surge ...

Gilead Sciences Stock Is Rallying - And the Reason Why May Sicken You

6 Reasons to Buy Gilead Sciences Stock | The Motley Fool

Here's Why Gilead Sciences Stock Surged 21% in a Month

El Tribunal Supremo escucha los argumentos sobre los atletas ...

August 4 coronavirus news

Mariam Sunny | Reuters

Trump officials say trade deal reached with China

Gilead's CEO: We are appealing the case

Gilead-Kite: A New Transformative Deal For Biotech

Gilead's Path to Equitable Global COVID-19 Treatment Access